203
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Concurrent and Post COVID-19 Ophthalmological Implications

, ORCID Icon, ORCID Icon & ORCID Icon
Pages 4467-4473 | Published online: 18 Nov 2021

References

  • Chen Z, Yuan G, Duan F, et al. Ocular involvement in Coronavirus disease 2019: up-to-date information on its manifestation, testing, transmission, and prevention. Front Med. 2020;7:569126. doi:10.3389/fmed.2020.569126
  • Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of Coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–1720. doi:10.1056/NEJMoa2002032
  • Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China [published correction appears in Lancet. 2020 Jan 30]. Lancet. 2020;395(10223):497–506. doi:10.1016/S0140-6736(20)30183-5
  • Romero-Sánchez CM, Díaz-Maroto I, Fernández-Díaz E, et al. Neurologic manifestations in hospitalized patients with COVID-19: the ALBACOVID registry. Neurology. 2020;95(8):e1060–e1070. doi:10.1212/WNL.0000000000009937
  • High B, Hixon AM, Tyler KL, et al. Neurology and the COVID-19 pandemic: gathering data for an informed response. Neurol Clin Pract. 2021;11(2):e48–e63. doi:10.1212/CPJ.0000000000000908
  • Badawi AE, Elsheikh SS, Addeen SZ, et al. An ophthalmic insight into novel coronavirus 2019 disease: a comprehensive review of the ocular manifestations and clinical hazards. J Curr Ophthalmol. 2020;32(4):315–328. doi:10.4103/JOCO.JOCO_255_20
  • Bertoli F, Veritti D, Danese C, et al. Ocular findings in COVID-19 patients: a review of direct manifestations and indirect effects on the eye. J Ophthalmol. 2020;2020:4827304. doi:10.1155/2020/4827304
  • Aggarwal K, Agarwal A, Jaiswal N, et al. Ocular surface manifestations of coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis. PLoS One. 2020;15(11):e0241661. doi:10.1371/journal.pone.0241661
  • Ahuja AS, Farford BA, Forouhi M, et al. The ocular manifestations of COVID-19 through conjunctivitis. Cureus. 2020;12(12):e12218. doi:10.7759/cureus.12218
  • Wu P, Duan F, Luo C, et al. Characteristics of ocular findings of patients with Coronavirus disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmol. 2020;138(5):575–578. doi:10.1001/jamaophthalmol.2020.1291
  • Chen L, Liu M, Zhang Z, et al. Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease. Br J Ophthalmol. 2020;104(6):748–751. doi:10.1136/bjophthalmol-2020-316304
  • Navel V, Chiambaretta F, Dutheil F. Haemorrhagic conjunctivitis with pseudomembranous related to SARS-CoV-2. Am J Ophthalmol Case Rep. 2020;19:100735. doi:10.1016/j.ajoc.2020.100735
  • Bostanci Ceran B, Ozates S. Ocular manifestations of coronavirus disease 2019. Graefes Arch Clin Exp Ophthalmol. 2020;258(9):1959–1963. doi:10.1007/s00417-020-04777-7
  • Marinho PM, Marcos AAA, Romano AC, et al. Retinal findings in patients with COVID-19. Lancet. 2020;395(10237):1610. doi:10.1016/S0140-6736(20)31014-X
  • Invernizzi A, Torre A, Parrulli S, et al. Retinal findings in patients with COVID-19: results from the SERPICO-19 study. EClinicalMedicine. 2020;27:100550. doi:10.1016/j.eclinm.2020.100550
  • Pirraglia MP, Ceccarelli G, Cerini A, et al. Retinal involvement and ocular findings in COVID-19 pneumonia patients. Sci Rep. 2020;10(1):17419. doi:10.1038/s41598-020-74446-6
  • Danthuluri V, Grant MB. Update and recommendations for ocular manifestations of COVID-19 in adults and children: a narrative review. Ophthalmol Ther. 2020;9(4):853–875. doi:10.1007/s40123-020-00310-5
  • World Health Organization. Clinical management of Severe Acute Respiratory Infection (SARI) when COVID-19 disease is suspected interim guidance; 2020. Available from: https://apps.who.int/iris/bitstream/handle/10665/331446/WHO-2019-nCoV-clinical-2020.4-eng.pdf?sequence=1&isAllowed=y. Accessed March 13, 2020.
  • Loon SC, Teoh SC, Oon LL, et al. The severe acute respiratory syndrome coronavirus in tears. Br J Ophthalmol. 2004;88(7):861–863. doi:10.1136/bjo.2003.035931
  • Zhang Y, Xiao M, Zhang S, et al. Coagulopathy and antiphospholipid antibodies in patients with Covid-19. N Engl J Med. 2020;382(17):e38. doi:10.1056/NEJMc2007575
  • Sheth JU, Narayanan R, Goyal J, et al. Retinal vein occlusion in COVID-19: a novel entity. Indian J Ophthalmol. 2020;68(10):2291–2293. doi:10.4103/ijo.IJO_2380_20
  • Landecho MF, Yuste JR, Gándara E, et al. COVID-19 retinal microangiopathy as an in vivo biomarker of systemic vascular disease? J Intern Med. 2021;289(1):116–120. doi:10.1111/joim.13156
  • Fernández Alcalde C, Granados Fernández M, Nieves Moreno M, et al. COVID-19 ocular findings in children: a case series. World J Pediatr. 2021;17(3):329–334. doi:10.1007/s12519-021-00418-z
  • Sarkar S, Gokhale T, Choudhury SS, et al. COVID-19 and orbital mucormycosis [published correction appears in Indian J Ophthalmol. 2021 Jul;69(7):1978]. Indian J Ophthalmol. 2021;69(4):1002–1004. doi:10.4103/ijo.IJO_3763_20
  • Bayram N, Ozsaygılı C, Sav H, et al. Susceptibility of severe COVID-19 patients to rhino-orbital mucormycosis fungal infection in different clinical manifestations. Jpn J Ophthalmol. 2021;65(4):515–525. doi:10.1007/s10384-021-00845-5
  • Mehta S, Pandey A. Rhino-orbital mucormycosis associated with COVID-19. Cureus. 2020;12(9):e10726. doi:10.7759/cureus.10726
  • Awal S, Biswas S, Awal S. Rhino-orbital mucormycosis in COVID-19 patients—a new threat? Egypt J Radiol Nucl Med. 2021;52(152). doi:10.1186/s43055-021-00535-9
  • El-Kholy NA, El-Fattah AMA, Khafagy YW. Invasive fungal sinusitis in post COVID-19 patients: a new clinical entity [published online ahead of print, 2021 May 19]. Laryngoscope. 2021. doi:10.1002/lary.29632
  • Maini A, Tomar G, Khanna D, Kini Y, Mehta H, Bhagyasree V. Sino-orbital mucormycosis in a COVID-19 patient: a case report. Int J Surg Case Rep. 2021;82:105957. doi:10.1016/j.ijscr.2021.105957